Pulmonary arterial hypertension (PAH) is a rare and progressive condition caused by high blood pressure in the arteries that ...

Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...

Pharmaceuticals’ treatment of pulmonary arterial hypertension was granted FDA orphan designation status, according to a post to ...

A leader in interventional pulmonology and advanced bronchoscopy, Dr. Gildea joins Olympus after 22 years with the Cleveland ...

Doctors warn that not every winter cough is caused by pollution—some may signal early pneumonia. Understanding your symptoms ...

The science around hormone therapy to treat menopause has changed a lot since the FDA issued warning labels 20 years ago. Now ...

Research and development expenses for the fiscal quarter ended September 30, 2025 were $2.5 million compared with $4.6 million for the fiscal quarter ended September 30, 2024. The decrease of $2.1 ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...